ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2015

Jun 26, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2015-06-24

Reporting Person: SOUTHWELL DAVID P (Director, See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-24	Stock Options (Right to Buy)	$5.03	A	150000	Acquired	2025-06-23	Common Stock (150000)	Direct

Footnotes

F1: The stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan. 25% of the options granted shall vest on the one year anniversary of February 17, 2015 and 1/36th of the remaining option grant shall vest on each monthly anniversary thereafter, subject to continued service through such dates.